Clinical Trials Browser

Phase 1/2 × OTHER × epratuzumab × Clear all

NCT01279707 2014-07-14

MARALL

Phase 1/2 Unknown

Burkitt Lymphoma, Recurrence

NCT01354457 2014-06-25

RIT 90YEpra

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma